EICHOR
● Active Not Recruiting
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Sponsor: Daiichi Sankyo
About this study
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an activating EGFR mutation (exon 19 deletion or L858R) who have received and progressed on or after at least 1 EGFR TKI and 1 platinum-based chemotherapy-containing regimen.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (123)
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| City of Hope | Duarte, California, United States | — |
| Moores Cancer Center at the UC San Diego Health | La Jolla, California, United States | — |
| Pacific Shores Medical Group | Long Beach, California, United States | — |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| University of California at Irvine | Orange, California, United States | — |
| Cedars Sinai | West Hollywood, California, United States | — |
| University of Colorado Denver - Anschutz Medical Campus | Aurora, Colorado, United States | — |
| Florida Cancer Specialists - South | Fort Myers, Florida, United States | — |
| AdventHealth Orlando | Orlando, Florida, United States | — |
| Memorial Healthcare System | Pembroke Pines, Florida, United States | — |
| Florida Cancer Specialist-North | St. Petersburg, Florida, United States | — |
+ 111 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.